Biolom developed a revolutionary nanoparticle-based biosensor device smaller than a grain of sand used for diagnosis and monitoring of diseases. This device would improve healthcare and save many lives. The state-of-the-art technology employed resulted in low-cost, fast turnaround time, easy-to-use, and efficient biosensor capable of simultaneous detection of multiple disease markers. The prototype has been tested in animal models for monitoring colorectal cancer and early detection of cardiovascular diseases. The next stage is to raise venture capital for conducting clinical trials.